SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-027657 from EQRx, Inc. (CIK 0001843762)

EQRx, Inc. (CIK 0001843762)
Date: March 2, 2023 · CIK: 0001843762 · Accession: 0001104659-23-027657

AI Filing Summary & Sentiment

File numbers found in text: 333-269972

Date
March 2, 2023
Author
/s/ Jami Rubin
Form
CORRESP
Company
EQRx, Inc. (CIK 0001843762)

Letter

EQRX, INC.

50 Hampshire Street

Cambridge MA 02139

VIA EDGAR

March 2, 2023

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re: EQRx, Inc.

Acceleration Request for Registration Statement on Form S-3

Filed February 23, 2023

File No. 333-269972

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, EQRx, Inc. hereby requests that the effective date and time of the above-referenced registration statement be accelerated to March 3, 2023, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable.

If you have any questions regarding this request, please contact William Collins of Goodwin Procter LLP at (617) 570-1447.

Sincerely,
EQRX, INC.

Show Raw Text
CORRESP
1
filename1.htm

EQRX, INC.

50 Hampshire Street

Cambridge MA 02139

VIA EDGAR

March 2, 2023

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Re: EQRx, Inc.

Acceleration Request for Registration Statement on Form S-3

Filed February 23, 2023

File No. 333-269972

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, EQRx,
Inc. hereby requests that the effective date and time of the above-referenced registration statement be accelerated to March 3, 2023,
at 4:30 p.m., Eastern Time, or as soon thereafter as practicable.

If you have any questions regarding this request, please contact William
Collins of Goodwin Procter LLP at (617) 570-1447.

    Sincerely,

    EQRX, INC.

    /s/ Jami Rubin

    Jami Rubin

    Chief Financial Officer

cc: Melanie Nallicheri, EQRx, Inc.

Dina Ciarimboli, EQRx, Inc.

William Collins, Goodwin Procter LLP

Marianne Sarrazin, Goodwin Procter LLP